GB2388294A - Nutritional composition - Google Patents

Nutritional composition Download PDF

Info

Publication number
GB2388294A
GB2388294A GB0318553A GB0318553A GB2388294A GB 2388294 A GB2388294 A GB 2388294A GB 0318553 A GB0318553 A GB 0318553A GB 0318553 A GB0318553 A GB 0318553A GB 2388294 A GB2388294 A GB 2388294A
Authority
GB
United Kingdom
Prior art keywords
nutritional composition
vitamin
vite
international
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0318553A
Other versions
GB0318553D0 (en
Inventor
Paul Rodney Clayton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNI VITE HEALTHCARE Ltd
Original Assignee
UNI VITE HEALTHCARE Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNI VITE HEALTHCARE Ltd filed Critical UNI VITE HEALTHCARE Ltd
Publication of GB0318553D0 publication Critical patent/GB0318553D0/en
Publication of GB2388294A publication Critical patent/GB2388294A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

A dietary supplement comprising: i) at least 50 mg Vitamin C; ii) at least 50 mg Vitamin E; iii) at least 2 mg of a carotene or carotenoid; iv) at least 20mg of a flavonoid; v) at least 200mg of an Omega 3 component; vi) at least 10mg of coenzyme Q10; vii) at least 100mg of glucosamine; viii) at least 10mg of betaine and/or žg of B Vitamins.

Description

GB 2388294 A continuation (72) Inventor(s): Paul Rodney Clayton (74) Agent
and/or Address for Service: Gill Jennings & Every Broadgate House, 7 Eldon Street, LONDON, EC2M 7LH, United Kingdom
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT
(19)WorldintellectualPropet yOrgant tion lttternatlonal T3ureau I 1111111111111111111111111111 11111111111111111111111111111111111111111111111 111 (43) International Publication Date (10) International Publication Number 253uy2(.o7.a) PCT WO 02/056710 A1 (51) International Patent Classification7: A23L 1/30, 1/3() {81) Designated States "national>: AK, AG, Al., AM, AT, AU, AZ,BA, HB,B(i,HR,BY,BZ,CA,CH,CN,CO,CR,CII, (21) International Application Number: PCT/GB02/00238 ('Z D1., DK. DM, 1)%, EC, EE, ES, Fl, GB, GV, GE, GH, GM,IIR,lilJ,ll),ll,[N,IS,JP,KE,KG.KP,KR,KZ,LC2, (22) Internaticoal Filiog Date: 21 January 2002 (21.01.200) I.K, I.R, I.S, 1.1', I.U, I.V, MA, MD, MG, MK, MN, MW, MX, M'Z., NC)1 N7., OM, PH, PL, PT, RO, RU, SD, SE, SCi, (25) Filiog Language: I.ngli!ih Sl, SK, Sl., 'I'J. TM, TN, TR, TT, TZ, tlA. ITG, US, UZ, VN, YlJ,'Z,A, /.M, Z.W.
(26) Publication Language: English (&4) Desigoated States /regional): ARIPO patent ((ill, (iM, (30) Priority Data: KE, LS, MW, MZ, SD, Sl., SZ, I'Z., UCi, i'.M, Z.W), 0101459.6 19 January 2001 (19.01.2001) GB Eurasian parcnt (AM, Al!,, HY, KC'., K7., M1), RIJ, 'I'J,1'M), European patent (A'l', Bti, C2ll C'Y, nE 1)K, ES, T:l, IR, (71) Applicant for all designated States ecept [IS): GB, GR, IE, IT, I.U, MC2, Nl., I>I: SF., TR) , C)API patent UNI-VITE HEALTHCARE LTD. I(iB/CiBI; IJni-Vite (BF: BJ, Cl', C(;, (21, CM, (iA, (iN, G<2, CiW, Ml., MR, House, 50 Ayicsbury Road, Aston ('linton, Ayleshury, NE, SN, TD, TG) Bucks. HP22 SAII (GB).
_ Published: = (72) loveotor; and --- with international search report = (7S) loveotor/Applicant (/or lIS onl): CLAYTON, Paul, -- before the expiration of the time limit for amending the = Rodney {GB/GB]; Uni-Vite Healthcare l.td., IJnj-Vite claims and to be republished in Ihe event of receipt of llousc, 50 Aylcsbury Road, Aston (2linton. Ayleshury, amendments _ Bucks. HP22 SAH (GB).
- tor two-letter codes and other abbreviations. refer to the "Guid (74) Ageot: GILL JENNINGS & EVERY; Btadgate House, ance Notes on Codes and Abbreviations " appearing at the begin - 7 Eldon Street, I.ondon EC2M 71. H (CiB). ning of each regular issue of the f'C'T Gazette.
- - = = = = ó o _4 o - (S4) Title: NUTRITIONAL COMPOSITION o O (S7) Abstract: A dietary supplement comprising: i) a: least 5() mg Vitamin C; ii) at least 50 mg Vitamin E; iii) at least 2 mg of a carotene orcarotenoiti; iv) at least20mg of a flavonoio; v) at icast (X) mg ofan Omcga 3 component, viat least 1() mg ot coen7yme Q10; vii) at least l(X) mg of glucosamine; viii) at least IU mg of betaine and/or pg of B Vitamins.
GB0318553A 2001-01-19 2002-01-21 Nutritional composition Withdrawn GB2388294A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0101459.6A GB0101459D0 (en) 2001-01-19 2001-01-19 Nutritional composition
PCT/GB2002/000238 WO2002056710A1 (en) 2001-01-19 2002-01-21 Nutritional composition

Publications (2)

Publication Number Publication Date
GB0318553D0 GB0318553D0 (en) 2003-09-10
GB2388294A true GB2388294A (en) 2003-11-12

Family

ID=9907141

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0101459.6A Ceased GB0101459D0 (en) 2001-01-19 2001-01-19 Nutritional composition
GB0318553A Withdrawn GB2388294A (en) 2001-01-19 2002-01-21 Nutritional composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0101459.6A Ceased GB0101459D0 (en) 2001-01-19 2001-01-19 Nutritional composition

Country Status (2)

Country Link
GB (2) GB0101459D0 (en)
WO (1) WO2002056710A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005022321A1 (en) * 2005-05-10 2006-11-16 Müller-Burzler, Henning Composition, useful e.g. as nutritional supplement, comprises vitamin C, vitamin E, coenzyme Q10, carotinoid e.g. beta-carotin, selenium, zinc, and copper, where the components are from natural plant and animal source
AU2021214954B2 (en) * 2020-01-27 2023-06-29 Frimline Private Limited Pharmaceutical composition for reducing protein bound uremic toxins

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015488A2 (en) * 1993-01-08 1994-07-21 Technolizenz Ets Rehydration drink
EP0652012A1 (en) * 1989-03-27 1995-05-10 Albert Naito Combination of sugars with animo acids and other drugs
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
EP0913155A2 (en) * 1997-10-24 1999-05-06 Pharma Nord (UK) Ltd. Pharmaceutical formulation for treating liver disorders
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
EP0960572A1 (en) * 1998-05-12 1999-12-01 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
DE20116346U1 (en) * 2001-10-05 2001-12-20 Orthomol Pharmazeutische Vertr Micronutrient combination product, among others with vitamins and carotenoids

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652012A1 (en) * 1989-03-27 1995-05-10 Albert Naito Combination of sugars with animo acids and other drugs
WO1994015488A2 (en) * 1993-01-08 1994-07-21 Technolizenz Ets Rehydration drink
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
EP0913155A2 (en) * 1997-10-24 1999-05-06 Pharma Nord (UK) Ltd. Pharmaceutical formulation for treating liver disorders
EP0960572A1 (en) * 1998-05-12 1999-12-01 N.V. Nutricia Nutritional composition for the treatment of pressure ulcers
DE20116346U1 (en) * 2001-10-05 2001-12-20 Orthomol Pharmazeutische Vertr Micronutrient combination product, among others with vitamins and carotenoids

Also Published As

Publication number Publication date
GB0318553D0 (en) 2003-09-10
GB0101459D0 (en) 2001-03-07
WO2002056710A1 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
Bender Nutritional biochemistry of the vitamins
Zhu et al. Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine
Dinis-Oliveira Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity
Kirkland Niacin requirements for genomic stability
Liu et al. Natural polyphenol disposition via coupled metabolic pathways
Potter Nutrition and colorectal cancer
Xu et al. Integrative analyses of widely targeted metabolic profiling and transcriptome data reveals molecular insight into metabolomic variations during apple (Malus domestica) fruit development and ripening
Marnewick et al. Modulation of hepatic drug metabolizing enzymes and oxidative status by rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia), green and black (Camellia sinensis) teas in rats
Kempson et al. Betaine transport in kidney and liver: use of betaine in liver injury
Said et al. Riboflavin uptake by human-derived colonic epithelial NCM460 cells
Bieri et al. Expressing dietary values for fat-soluble vitamins: changes in concepts and terminology
Huang et al. Functional expression of Na (+)-dependent nucleoside transport systems of rat intestine in isolated oocytes of Xenopus laevis. Demonstration that rat jejunum expresses the purine-selective system N1 (cif) and a second, novel system N3 having broad specificity for purine and pyrimidine nucleosides.
Traber Vitamin E and K interactions–a 50-year-old problem
Nabokina et al. A high-affinity and specific carrier-mediated mechanism for uptake of thiamine pyrophosphate by human colonic epithelial cells
Twomey et al. A ketocarotenoid‐based colour polymorphism in the Sira poison frog Ranitomeya sirensis indicates novel gene interactions underlying aposematic signal variation
He et al. Regioselective synthesis of plant (iso) flavone glycosides in Escherichia coli
Sticha et al. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on DNA adduct formation by a mixture of benzo [a] pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung
Bolling et al. The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes
GB2388294A (en) Nutritional composition
Carmona et al. Improvement of antioxidant properties in fruit from two blood and blond orange cultivars by postharvest storage at low temperature
Zunino et al. Resveratrol alters proliferative responses and apoptosis in human activated B lymphocytes in vitro
Arif et al. Phytocannabinoids biosynthesis in angiosperms, fungi, and liverworts and their versatile role
Dixit et al. Non‐targeted metabolomics approach to assess the brown marine macroalga Dictyota dichotoma as a functional food using liquid chromatography with mass spectrometry
Zhu et al. Metabolic profiling and transcriptional analysis of carotenoid accumulation in a red-fleshed mutant of pummelo (Citrus grandis)
Boonpawa et al. A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)